Evidence map›Paper›PMID 27709331›Full record

ReviewCurrent treatment options in gastroenterology2016

How to Diagnose and Treat Functional Chest Pain.

Jose M Remes-Troche

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05402462 (Esophageal Motility Disorders in Patients With Non-cardiac Chest Pain at Assiut University Hospital), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05402462 unknown statusnot on this mapstarted 2022, after this paper: background citation

Esophageal Motility Disorders in Patients With Non-cardiac Chest Pain at Assiut University Hospital

TypeobservationalSponsorAssiut UniversityRan2022 to 2024Enrolled90ConditionsEsophageal Motility DisordersArmsupper endoscopy
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jose M Remes-TrocheDigestive Physiology and Gastrointestinal Motility Laboratory, Medical-Biological Research Institute (IIMB), Universidad Veracruzana, Veracruz, Veracruz, Mexico. joremes@uv.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementChest pain that is not explained by reflux disease or cardiac, musculoskeletal, mucosal, or motor esophageal abnormalities is classified as functional chest pain (FCP). Although several mechanisms are involved, esophageal hypersensitivity plays a major role and it could be considered a biomarker for FCP. Psychologic comorbidity such as anxiety, neuroticism, depression, and somatization is common. When the diagnosis of FCP is suspected, patients should undergo evaluation with esophageal motility testing, endoscopy, 24-h esophageal pH monitoring, and in some cases, sensory tests. Once the diagnosis of FCP has been established, treatment options rely on controlling patients' symptoms. Medical treatment has focused predominantly on medications that target pain, such as antidepressants and other pain neuromodulators. Non-pharmacologic interventions with complementary behavioral treatments, such as cognitive behavioral therapy, biofeedback, and hypnosis, have recently been recognized as useful in FCP patients. The latest findings on the evaluation and treatment of FCP are outlined herein.

Indexed as

AntidepressantsEsophagusFunctional chest painHypersensitivityPain modulators

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.